Verdence Capital Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,651
| Closed | -$503K | – | 556 |
|
|
2023
Q1 | $503K | Buy |
3,651
+1
| +0% | +$138 | 0.06% | 307 |
|
|
2022
Q4 | $473K | Hold |
3,650
| – | – | 0.06% | 290 |
|
|
2022
Q3 | $403K | Hold |
3,650
| – | – | 0.06% | 315 |
|
|
2022
Q2 | $274K | Hold |
3,650
| – | – | 0.04% | 411 |
|
|
2022
Q1 | $285K | Hold |
3,650
| – | – | 0.03% | 434 |
|
|
2021
Q4 | $329K | Sell |
3,650
-140
| -4% | -$12.6K | 0.04% | 386 |
|
|
2021
Q3 | $350K | Sell |
3,790
-1,610
| -30% | -$149K | 0.05% | 345 |
|
|
2021
Q2 | $420K | Buy |
5,400
+1,400
| +35% | +$109K | 0.06% | 283 |
|
|
2021
Q1 | $298K | Buy |
4,000
+50
| +1% | +$3.73K | 0.05% | 358 |
|
|
2020
Q4 | $673K | Sell |
3,950
-3,500
| -47% | -$596K | 0.13% | 167 |
|
|
2020
Q3 | $1.05M | Buy |
+7,450
| New | +$1.05M | 0.24% | 111 |
|